COMPASS Pathways plc (CMPS)
Last Price$3.7(6.6%)
Market Cap$253.4M
CMPS Rating
CMPS Quality rating performance
CMPS Intrinsic Value
Key Highlights:
As of Mar 03, 2025 CMPS Relative Value is $2.6, which is overvalued by 28.8%, compared to current share price of $3.7.
As of Mar 03, 2025 CMPS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $3.7.
CMPS Share Price History
1W (0.8%)
1M (14.8%)
6M (49.2%)
YTD (59.2%)
1Y (68.1%)
3Y (72.4%)
5Y (87.3%)
10Y (87.3%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CMPS Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$253.4M
$79.0M
$3,682.8K
($105.3M)
Shares Outstanding
69M
Employees
N/A
Growth (CAGR)
N/A
67.9%
13.08%
83.4%
1.96%
Profitability
46.6%
(4,576.2%)
(3,926.5%)
(2,858.8%)
(2,859.2%)
72.6%
Intrinsic Value
$2.6 (30.5% overvalued)
N/A
$2.6
($16.9)
N/A
Valuation (LTM)
Return on Capital
(69.2%)
(55.2%)
(1,398.7%)
(69.1%)
(19.2%)
2,161.4%
2,161.4%
Financial Health
($174.4M)
1.7x
(37.6x)
16.9%
Dividends
Earnings
May 06, 2025
MISS by 0.0%
BEAT by (7.1%)
(9.7%)
5 Beat & 5 Miss
CMPS Stock Financials
CMPS Income Statement Metrics
Annual
Quarterly
LTM
CMPS Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($97.4M) -7.6% YoY
Capital Expenditure (CAPEX)
($66.0K) -88.9% YoY
Free Cash Flow (FCF)
($97.4M) -8.0% YoY
CMPS Income Statement Overview
Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
CMPS Balance Sheet Overview
Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$276.0M
Current assets ($261.3M, 94.7% of total)
$220.2M (79.8%)
$28.9M (10.5%)
Other current assets
$12.2M (4.4%)
Non-current assets ($14.7M, 5.3% of total)
$469.0K (0.2%)
$4,729.0K (1.7%)
$0.0 (0.0%)
Other non-current assets
$9,493.0K (3.4%)
Financial position
($187.1M)
Cash & Short-term
Investments
Total Debt
CMPS Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CMPS Earnings Surprises
Crunching data... Almost there!
CMPS Dividends
CMPS Dividend Yield
Crunching data... Almost there!
CMPS Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CMPS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$253.4M | 5.2 | $2.6 30.5% overvalued | (68.1%) | $3,682.8K | ($105.3M) | N/A | (2,859.2%) | 46.6% | (1,398.7%) | 16.9% | |
$78.9B | 6.3 | $368.8 18.5% undervalued | (0.1%) | $70.6B | $5,639.0M | 8.7% | 8.0% | 39.2% | 22.1% | 7.3% | |
$14.6B | 5.5 | $71.8 204.9% undervalued | 28.7% | €19.3B | €2,416.2M | (0.6%) | 12.5% | 24.6% | 3.8% | 69.6% | |
$12.2B | 6.7 | $329.6 130.3% undervalued | 13.8% | $12.8B | $1,470.3M | 5.6% | 11.5% | 48.9% | 11.8% | 544.4% | |
$12.0B | 6.0 | $378.2 203.6% undervalued | 32.9% | $20.7B | $1,116.0M | 0.6% | 5.4% | 35.6% | 10.2% | 154.1% | |
$11.7B | 6.2 | $315.7 79.6% undervalued | 1.0% | $15.8B | $1,123.3M | 10.8% | 7.1% | 51.2% | 15.6% | 73.3% | |
$10.0B | 5.6 | $72.1 27.8% overvalued | 34.3% | $5,373.2M | $280.2M | 11.9% | 5.2% | 29.3% | 11.2% | 12.4% | |
$8,767.7M | 7.0 | $397.3 32.8% overvalued | (6.2%) | $2,431.3M | $368.0M | 7.4% | 15.1% | 50.5% | 23.6% | 12.6% | |
$7,406.8M | 5.6 | $95.8 26.2% overvalued | 3.3% | $4,233.2M | $188.9M | 13.5% | 4.5% | 14.2% | 6.6% | 104.7% | |
$5,760.8M | 6.3 | $24.0 29.4% overvalued | 3.5% | $4,998.2M | $287.8M | 16.2% | 5.8% | 20.0% | 12.2% | 0.0% | |
$2,714.5M | 5.9 | $40.8 39.3% undervalued | (65.8%) | $3,154.0M | ($560.7M) | 7.7% | (17.8%) | 61.1% | 19.6% | 65.3% |
FAQ
What is COMPASS Pathways plc (CMPS) stock rating?
As of today, COMPASS Pathways plc has a stock rating of N/A (out of 10), which is considered Great.
is COMPASS Pathways plc (CMPS) a good stock to buy?
As of today, COMPASS Pathways plc has a Great stock rating, which is N/A undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.